Despite the fact that the diagnostic approach to AATD currently varies between different health institutions and countries [63], diagnosis currently begins with the determination of AAT levels in blood as the main form of screening for the disease. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.